Black adults treated for common arterial disease are at greater risk of amputation, death than white adults, researchers show

About 6.5 million Americans over the age of 40 suffer from peripheral arterial disease (PAD). In the U.S., Black adults in their 50s are at least twice as likely to suffer from PAD as their white counterparts, a disparity that…
Research letter highlights low adoption of supervised exercise therapy for PAD

A research letter published in Circulation: Cardiovascular Quality and Outcomes highlights a “very low” utilization of supervised exercise therapy (SET) in symptomatic peripheral arterial disease (PAD) patients during the first 19 months after approval by the Centers for Medicare & Medicaid Services (CMS)…
Study identifies new genetic factors associated with AAA risk

The American Heart Association (AHA) recently announced the publication of a study identifying 14 new genes linked to an increased risk of abdominal aortic aneurysm (AAA). Previous studies have detected 10 locations in the human genome associated with potential AAA…
AHA issues call to action to prevent VTE in hospitalised patients

Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the U.S. and worldwide. A new policy statement from the American Heart Association (AHA) provides a focused review of VTE, risk scoring systems, preventive measures for the hospital…
VIVA Physicians publishes analysis evaluating mortality and paclitaxel-coated devices

An individual patient-level data (IPD) analysis of the safety of paclitaxel-containing devices (PTXD), conducted by VIVA Physicians, identified an absolute 4.6% increased mortality risk associated with PTXD use. The analysis, based on the most complete available data set of mortality…

